Polymerase chain reaction

Nephros to Present at Zooming with LD

Retrieved on: 
Monday, July 13, 2020

Daron Evans, President & CEO and Andy Astor, COO & CFO of Nephros will be giving the presentation and answering questions from investors.

Key Points: 
  • Daron Evans, President & CEO and Andy Astor, COO & CFO of Nephros will be giving the presentation and answering questions from investors.
  • Nephros is a commercial-stage company that develops and markets high performance water purification products and pathogen detection systems for medical and commercial markets.
  • Our products integrate Nephros ultrafilters with quantitative polymerase chain reaction (qPCR) technology to deliver actionable water pathogen information in real time.
  • Nephros commercial filters, including AETHER brand filters, improve the taste and odor of water, and reduce scale build-up in downstream equipment.

PerkinElmer Updates Second Quarter Outlook; To Hold Earnings Call on Tuesday, July 28, 2020

Retrieved on: 
Monday, July 13, 2020

Demand for the Companys RT-PCR and serology tests, RNA extraction systems and kits, and automated liquid handling instrumentation was particularly robust.

Key Points: 
  • Demand for the Companys RT-PCR and serology tests, RNA extraction systems and kits, and automated liquid handling instrumentation was particularly robust.
  • In total, COVID-19 related solutions contributed approximately $190 million of revenue in the second quarter.
  • PerkinElmer will release its second quarter 2020 financial results on Tuesday, July 28, 2020, after market close.
  • Organic revenue growth refers to the measure of comparing current period organic revenue with the corresponding period of the prior year.

Vela Diagnostics receives CE-IVD approval and Provisional Authorisation from the Health Sciences Authority in Singapore for automated COVID-19 detection test

Retrieved on: 
Monday, July 13, 2020

SINGAPORE, July 13, 2020 /PRNewswire/ -- Vela Diagnostics announced today that an automated version of its COVID-19 detection test, the ViroKeySARS-CoV-2 RT-PCR Test v2.0, has received the CE mark for in vitro diagnostic use as well as Provisional Authorisation from the Health Sciences Authority in Singapore.

Key Points: 
  • SINGAPORE, July 13, 2020 /PRNewswire/ -- Vela Diagnostics announced today that an automated version of its COVID-19 detection test, the ViroKeySARS-CoV-2 RT-PCR Test v2.0, has received the CE mark for in vitro diagnostic use as well as Provisional Authorisation from the Health Sciences Authority in Singapore.
  • The ViroKey SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR Test that detects SARS-CoV-2 by targeting conserved regions of the SARS-CoV-2 genome, specifically the ORF1a and N genes.
  • The automated test is optimized for a workflow consisting of theSentosa SX101 instrument, in conjunction with theSentosaSA201 instrument or the ABI 7500 Fast Dx.The automated workflow enables high throughput testing with significantly reduced hands-on time.
  • In April this year, an earlier version of the test, the ViroKey SARS-CoV-2 RT-PCR Test, also received the CE mark and Provisional Authorisation from the Health Sciences Authority in Singapore.

Webinar Will Introduce Faster And More Cost-Effective Wastewater Testing For Early Detection Of COVID-19

Retrieved on: 
Tuesday, July 7, 2020

As more municipalities turn to wastewater monitoring for early detection of COVID-19, these three companies are uniquely positioned to provide an end-to-end solution to improve the process.

Key Points: 
  • As more municipalities turn to wastewater monitoring for early detection of COVID-19, these three companies are uniquely positioned to provide an end-to-end solution to improve the process.
  • GT Molecular ,has developed a Molecular Diagnostic Assay for the rapid detection and absolute quantification of SARS-CoV-2 RNA in wastewater samples.
  • "GT Molecular continues to provide valuable partnership to provide early detection of COVID-19 community spread through innovative wastewater epidemiology techniques."
  • Wastewater professionals in municipalities currently monitoring wastewater for early detection of COVID-19 or interested in starting a sampling program are encouraged to attend this timely and informative presentation.

Assessment of the COVID-19 Detection Kits Market 2020-2025 - RT-PCR Assay Kits to Witness Healthy Growth

Retrieved on: 
Monday, July 6, 2020

DUBLIN, July 6, 2020 /PRNewswire/ -- The "COVID-19 Detection Kits Market - Growth, Trends and Forecasts (2020-2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 6, 2020 /PRNewswire/ -- The "COVID-19 Detection Kits Market - Growth, Trends and Forecasts (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
  • The Global COVID-19 Detection Kits Market is expected to register a CAGR of 8% during the forecast period.
  • Reverse transcription-polymerase chain reaction (RT-PCR) assay kits are estimated to witness healthy growth in the future due to its high sensitivity and specificity.
  • The COVID-19 Detection Kits Market is moderately competitive and consists of several major players.

Biotech Company Psomagen COVID-19 Test Granted Emergency Use Authorization

Retrieved on: 
Monday, July 6, 2020

Rockville, MD, July 06, 2020 (GLOBE NEWSWIRE) -- COVID-19 test services developed by Psomagen have been granted Emergency Use Authorization from the Food and Drug Administration on June 30, 2020.

Key Points: 
  • Rockville, MD, July 06, 2020 (GLOBE NEWSWIRE) -- COVID-19 test services developed by Psomagen have been granted Emergency Use Authorization from the Food and Drug Administration on June 30, 2020.
  • The Psoma COVID-19 RT Test from Psomagen is an in-vitro lab developed test (LDT) that uses real-time reverse transcription-polymerase chain reaction (RT-PCR) to provide fast, accurate results.
  • The test provides extremely high accuracy and can be used to screen patients with trace amounts of COVID-19.
  • During Psomagens clinical trials for Psoma COVID-19 RT test, the company confirmed 100% consistency in both the positive and negative groups.

Global Linear Motion System Market Trends 2020-2025 - RT-PCR Testing is a Reliable, Highly Sensitive Method for Detecting COVID-19

Retrieved on: 
Monday, July 6, 2020

DUBLIN, July 6, 2020 /PRNewswire/ -- The "Linear Motion System Market - Growth, Trends, Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 6, 2020 /PRNewswire/ -- The "Linear Motion System Market - Growth, Trends, Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
  • There is an increasing need for ongoing industrialization along with the need for modern automatic systems in various industries, thereby driving the growth of linear motion systems.
  • Reverse transcription polymerase chain reaction is a reliable, highly sensitive method for detecting the COVID-19 coronavirus disease.
  • The linear motion system market is expected to be fragmented in nature owing to the presence of various players across the globe.

General Biologicals Corporation (GBC) Develops COVID-19 Testing Solutions for Antigen and Antibody Detection

Retrieved on: 
Monday, July 6, 2020

TAIPEI, July 6, 2020 /PRNewswire/ -- General Biologicals Corporation (GBC), a Taiwanese medical device company has developed the GB SARS-CoV-2 Real-Time RT-PCR ("PCR Kit"): a reliable molecular testing kit for the detection of the novel coronavirus in humans.

Key Points: 
  • TAIPEI, July 6, 2020 /PRNewswire/ -- General Biologicals Corporation (GBC), a Taiwanese medical device company has developed the GB SARS-CoV-2 Real-Time RT-PCR ("PCR Kit"): a reliable molecular testing kit for the detection of the novel coronavirus in humans.
  • The testing kit also features internal control (IC) as an indicator of the RT-PCR performance, which can reduce the results of false-negatives.
  • In addition to its PCR Kit, GBC is currently developing other COVID-19 testing solutions including a SARS-CoV-2 antigen test and antibody test.
  • Founded in 1984, General Biologicals Corporation (GBC) is a developer and manufacturer of diagnostics and pharmaceutical products headquartered in Taiwan.

Ecolog Announces Walk-In COVID-19 Testing Facility at Eindhoven Airport

Retrieved on: 
Friday, July 3, 2020

The testing station provides citizens and residents as well as passengers, with the opportunity to perform a COVID-19 q-PCR test with a short turn-around time.

Key Points: 
  • The testing station provides citizens and residents as well as passengers, with the opportunity to perform a COVID-19 q-PCR test with a short turn-around time.
  • It offers screening, testing, and diagnostic solution to help build economic continuity and enhance public health.
  • The solution has been successfully deployed in Luxembourg, enabling the pioneering nation-wide COVID-19 testing project by the government and LIH.
  • Ecolog, in partnership with Pro Health Medical (a RIVM registered COVID-19 laboratory), will start operating the testing facility in July, providing everyone interested with the opportunity to get tested.

Ecolog Announces Walk-In COVID-19 Testing Facility at Eindhoven Airport

Retrieved on: 
Friday, July 3, 2020

The testing station provides citizens and residents as well as passengers, with the opportunity to perform a COVID-19 q-PCR test with a short turn-around time.

Key Points: 
  • The testing station provides citizens and residents as well as passengers, with the opportunity to perform a COVID-19 q-PCR test with a short turn-around time.
  • It offers screening, testing, and diagnostic solution to help build economic continuity and enhance public health.
  • The solution has been successfully deployed in Luxembourg, enabling the pioneering nation-wide COVID-19 testing project by the government and LIH.
  • Ecolog, in partnership with Pro Health Medical (a RIVM registered COVID-19 laboratory), will start operating the testing facility in July, providing everyone interested with the opportunity to get tested.